Cargando…
Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
The pathophysiologic process of Alzheimer's disease (AD) begins years before the diagnosis of clinical dementia. This concept of preclinical AD has arisen from the observation of AD pathologic findings such as senile plaques and neurofibrillary tangles in the brains of people who at the time of...
Autores principales: | Shim, Yong S., Morris, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131540/ https://www.ncbi.nlm.nih.gov/pubmed/21779293 http://dx.doi.org/10.3988/jcn.2011.7.2.60 |
Ejemplares similares
-
Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012) -
Changes in Ocular Biomarkers from Normal Cognitive Aging to Alzheimer’s Disease: A Pilot Study
por: Chaitanuwong, Pareena, et al.
Publicado: (2023) -
Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging
por: Motsinger-Reif, Alison A, et al.
Publicado: (2013) -
Dissociating Normal Aging from Alzheimer’s Disease: A View from Cognitive Neuroscience
por: Toepper, Max
Publicado: (2017) -
Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
por: Bauer, Corinna M., et al.
Publicado: (2018)